Financial Ratios

PAN DRUGS LTD.

NSE : NABSE : 531440ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE2.050 (0 %)
PREV CLOSE ( ) 2.05
OPEN PRICE ( ) 2.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )2.05 2.05
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012
Operational & Financial Ratios
   Earnings Per Share (Rs)0.88-0.87-3.00
   CEPS(Rs)2.810.78-1.55
   DPS(Rs)0.000.000.00
   Book NAV/Share(Rs)-26.01-26.90-26.02
   Tax Rate(%)0.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-0.12-6.51-3.86
   EBIT Margin(%)0.92-1.06-3.93
   Pre Tax Margin(%)0.80-1.26-4.24
   PAT Margin (%)0.80-1.26-4.24
   Cash Profit Margin (%)2.551.13-2.19
Performance Ratios
   ROA(%)1.35-1.40-4.73
   ROE(%)0.000.000.00
   ROCE(%)2.86-2.05-7.79
   Asset Turnover(x)1.681.111.12
   Sales/Fixed Asset(x)2.711.922.15
   Working Capital/Sales(x)-2.12-1.36-1.42
Efficiency Ratios
   Fixed Capital/Sales(x)0.370.520.47
   Receivable days52.6472.9478.49
   Inventory Days24.2736.8736.49
   Payable days110.06135.53103.74
Valuation Parameters
   PER(x)0.000.000.00
   PCE(x)0.000.000.00
   Price/Book(x)0.000.000.00
   Yield(%)
   EV/Net Sales(x)0.681.081.04
   EV/Core EBITDA(x)22.5571.86-49.11
   EV/EBIT(x)65.65-90.54-23.49
   EV/CE(x)0.961.081.03
   M Cap / Sales0.000.000.00
Growth Ratio
   Net Sales Growth(%)58.86-1.980.00
   Core EBITDA Growth(%)219.03169.200.00
   EBIT Growth(%)238.0773.730.00
   PAT Growth(%)200.9070.910.00
   EPS Growth(%)200.9070.910.00
Financial Stability Ratios
   Total Debt/Equity(x)-2.35-2.32-2.37
   Current Ratio(x)0.430.390.42
   Quick Ratio(x)0.340.310.33
   Interest Cover(x)7.84-5.16-12.81
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.